Show simple item record

dc.contributor.authorAssemblée mondiale de la Santé, 2
dc.coverage.spatialGenèveen
dc.date.accessioned2014-02-16T15:16:09Z
dc.date.available2014-02-16T15:16:09Z
dc.date.issued1949
dc.identifier.govdocA2/24
dc.identifier.govdocA2/24 Add.1
dc.identifier.urihttp://www.who.int/iris/handle/10665/103126
dc.descriptionAssemblée mondiale de la Santé, deuxième sessionen
dc.description2 p.en
dc.language.isofren
dc.publisherOrganisation mondiale de la Santéen
dc.subjectPharmaceutical productsen
dc.subject.meshPharmaceutical Preparationsen
dc.subject.meshReference Standardsen
dc.subject.meshVaccinesen
dc.subject.meshHormonesen
dc.subject.meshVitaminsen
dc.subject.meshAnti-Bacterial Agentsen
dc.subject.meshBlood Group Antigensen
dc.titleComité d'experts pour la standardisation biologique : Rapport sur la troisième session : Point 8.16.1 de l'ordre du jour provisoireen
dc.typeGoverning body documentsen
dc.subject.meshqualifierstandardsen


Files in this item

Thumbnail

This item appears in the following Collection(‎s)‎

  • WHA2
    18 June - 2 July 1949

Show simple item record